Company Filing History:
Years Active: 1998-2012
Title: The Innovations of Paul L. Kornblith
Introduction
Paul L. Kornblith is a prominent inventor based in Pittsburgh, PA, known for his significant contributions to the field of medical diagnostics and therapeutics. With a total of 17 patents to his name, Kornblith has developed innovative methods that enhance the evaluation and treatment of tumors. His work is instrumental in advancing personalized medicine, particularly in the realm of cancer treatment.
Latest Patents
Kornblith's latest patents include groundbreaking technologies such as "Assaying Cellular Markers for the Evaluation of Tumors." This patent describes an improved system for assaying the expression of various markers, factors, or antigens on cultured cells for diagnostic purposes. It also facilitates the monitoring of the applicability of certain candidate therapeutic or chemotherapeutic agents and the progress of treatment with those agents. Another notable patent is "Methods for Determining Efficacy of Chemotherapeutic Agents." This innovation provides an improved system for screening multiple candidate therapeutic or chemotherapeutic agents for efficacy specific to a patient. By harvesting and culturing a tissue sample from the patient, the method allows for the objective identification of the best treatment or agent for that individual.
Career Highlights
Kornblith's career is marked by his role at Precision Therapeutics, Inc., where he applies his expertise to develop cutting-edge solutions in cancer treatment. His innovative approaches have garnered attention in the medical community, contributing to advancements in how treatments are tailored to individual patients.
Collaborations
Kornblith collaborates with talented professionals such as Sean McDonald and Sheri Gimigliano, who share his commitment to improving patient outcomes through innovative research and development.
Conclusion
Paul L. Kornblith's contributions to medical diagnostics and therapeutics exemplify the impact of innovation in healthcare. His patents and work at Precision Therapeutics, Inc. continue to pave the way for advancements in personalized medicine.